Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder for which numerous mouse models have been generated. In both AD patients and mouse models, there is increasing evidence that neuronal dysfunction occurs before the accumulation of β-amyloid (Aβ)-containing plaques and neurodegeneration. Characterization of the timing and nature of preplaque dysfunction is important for understanding the progression of this disease and to identify pathways and molecular targets for therapeutic intervention. Hence, we have examined the progression of dysfunction at the morphological, functional, and behavioral levels in the Tg2576 mouse model of AD. Our data show that decreased dendritic spine density, impaired long-term potentiation (LTP), and behavioral deficits occurred months before plaque deposition, which was first detectable at 18 months of age. We detected a decrease in spine density in the outer molecular layer of the dentate gyrus (DG) beginning as early as 4 months of age. Furthermore, by 5 months, there was a decline in LTP in the DG after perforant path stimulation and impairment in contextual fear conditioning. Moreover, an increase in the Aβ42/Aβ40 ratio was first observed at these early ages. However, total amyloid levels did not significantly increase until ≈18 months of age, at which time significant increases in reactive astrocytes and microglia could be observed. Overall, these data show that the perforant path input from the entorhinal cortex to the DG is compromised both structurally and functionally, and this pathology is manifested in memory defects long before significant plaque deposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The widely used Tg2576 mouse model expresses mutant human APP and displays decreased spine density in the CA1 and dentate gyrus, well before the development of amyloid plaques, further evidence that soluble Aβ oligomers initiate at least some Alzheimer’s disease–related pathology68,95.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [95]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whereas high-frequency stimulation significantly increased the magnitude of long-term potentiation (LTP) at Schaffer collateral (SC)-CA1 synapses in the hippocampus of wild type (WT) mice, LTP was significantly impaired in 6-to 7-mo-old APP/PS1 mice (17,18).”
From IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline (2016) · cites this paper as [17]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is different from the progression in Tg2576, which manifests synaptic damage at an early stage of pathological development (4.5 months) [68,69] with a corresponding decrease in synaptic density markers [70] prior to Aβ plaque development (10 months) [71] and cognitive deficiencies (one year) [72,73].”
From Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice (2019) · cites this paper as [69]
The cited source says what the claim attributes to it.
In the citing paper
“Tg2576 mice began to show impaired LTP and synaptic transmission in dentate gyrus (DG) at 4–5 mo or older (Jacobsen et al., 2006).”
From VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology (2011) · cites this paper as Jacobsen et al., 2006
In the citing paper
“The widely used Tg2576 mouse model expresses mutant human APP and displays decreased spine density in the CA1 and dentate gyrus, well before the development of amyloid plaques, further evidence that soluble Aβ oligomers initiate at least some Alzheimer’s disease–related pathology68,95.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [95]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2005) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,687
Life and Death of Neurons in the Aging Brain
Morrison, J. H., & Hof, P. R. (1997) · Science · doi:10.1126/science.278.5337.412 · Cited by 1,344
Self-citationDeciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
Cited by
Items 101–200 of 789
PTEN recruitment controls synaptic and cognitive function in Alzheimer's models
Knafo, S., Sánchez‐Puelles, C., Palomer, E., Delgado, I., Draffin, J. E., Mingo, J., Wahle, T., Kaleka, K. S., Mou, L., Pereda-Pérez, I., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4225 · Cited by 161
Amyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer’s disease
Ma, T., & Klann, E. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07506.x · Cited by 132
D’Amelio, M., & Rossini, P. M. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.07.001 · Cited by 158
Insulin‐like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice
Pascual‐Lucas, M., Viana da Silva, S., Di Scala, M., Garcia‐Barroso, C., González‐Aseguinolaza, G., Mulle, C., Alberini, C. M., Cuadrado‐Tejedor, M., & Garcia‐Osta, A. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404228 · Cited by 145
Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid‐β oligomers
Gandy, S., Simon, A. J., Steele, J. W., Lublin, A. L., Lah, J. J., Walker, L. C., Levey, A. I., Krafft, G. A., Levy, E., Checler, F., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22052 · Cited by 137
Keating, D. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04997.x · Cited by 141
Frydman‐Marom, A., Rechter, M., Shefler, I., Bram, Y., Shalev, D. E., & Gazit, E. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802123 · Cited by 143
Ma, T., Hoeffer, C. A., Wong, H., Massaad, C. A., Zhou, P., Iadecola, C., Murphy, M. P., Pautler, R. G., & Klann, E. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6566-10.2011 · Cited by 146
Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice
Killick, R., Scales, G., Leroy, K., Causevic, M., Hooper, C., Irvine, E. E., Choudhury, A. I., Drinkwater, L., Kerr, F., Al-Qassab, H., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.032 · Cited by 132
Amyloid-β: a potential link between epilepsy and cognitive decline
Romoli, M., Sen, A., Parnetti, L., Calabresi, P., & Costa, C. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00505-9 · Cited by 154
Castillo-Carranza, D. L., Guerrero-Muñoz, M. J., Sengupta, U., Hernandez, C., Barrett, A. D. T., Dineley, K., & Kayed, R. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4989-14.2015 · Cited by 149
“A reduced number of spines and abnormal morphology have been described previously in Tg2576 mice (Spires et al., 2005; Jacobsen et al., 2006).”
BackgroundMultiple events lead to dendritic spine loss in triple transgenic Alzheimer’s disease mice
Bittner, T., Fuhrmann, M., Burgold, S., Ochs, S. M., Hoffmann, N., Mitteregger, G., Kretzschmar, H., LaFerla, F. M., & Herms, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015477 · Cited by 149
“In addition, the spatio-temporal distribution of soluble A b might be different in 3xTg-AD compared to other AD mouse models that show an early decline in spine density [16,17].”
Kam, K., Duffy, Á. M., Moretto, J., LaFrancois, J. J., & Scharfman, H. E. (2016) · Scientific Reports · doi:10.1038/srep20119 · Cited by 140
Marchetti, C., & Marie, H. (2011) · revneuro · doi:10.1515/rns.2011.035 · Cited by 136
Calabrese, B., Shaked, G. M., Tabarean, I. V., Braga, J., Koo, E. H., & Halpain, S. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.02.006 · Cited by 114
Harris, J. A., Devidze, N., Halabisky, B., Lo, I., Thwin, M. T., Yu, G.-Q., Bredesen, D. E., Masliah, E., & Mucke, L. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5341-09.2010 · Cited by 146
“In addition to presynaptic degeneration, hAPP mice and patients with AD also show loss of dendrites and dendritic spines (Games et al., 1995; Moolman et al., 2004; Jacobsen et al., 2006; Rockenstein et al., 2007; Knobloch and Mansuy, 2008).”
BackgroundFukumoto, H., Takahashi, H., Tarui, N., Matsui, J., Tomita, T., Hirode, M., Sagayama, M., Maeda, R., Kawamoto, M., Hirai, K., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2884-10.2010 · Cited by 130
Use of Phosphatide Precursors to Promote Synaptogenesis
Wurtman, R. J., Cansev, M., Sakamoto, T., & Ulus, I. H. (2009) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-080508-141059 · Cited by 130
Bhattacharya, S., Haertel, C., Maelicke, A., & Montag, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089454 · Cited by 142
Alzheimer disease and platelets: how’s that relevant
Catricala, S., Torti, M., & Ricevuti, G. (2012) · Immunity & Ageing · doi:10.1186/1742-4933-9-20 · Cited by 130
Shankar, G. M., Leissring, M. A., Adame, A., Sun, X., Spooner, E., Masliah, E., Selkoe, D. J., Lemere, C. A., & Walsh, D. M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.021 · Cited by 123
Ho, L., Chen, L. H., Wang, J., Zhao, W., Talcott, S. T., Ono, K., Teplow, D., Humala, N., Cheng, A., Percival, S. S., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0916 · Cited by 126
Age dependence of primary motor cortex plasticity induced by paired associative stimulation
Tecchio, F., Zappasodi, F., Pasqualetti, P., Gennaro, L. D., Pellicciari, M. C., Ercolani, M., Squitti, R., & Rossini, P. M. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2007.10.023 · Cited by 142
p21-activated Kinase-aberrant Activation and Translocation in Alzheimer Disease Pathogenesis
Ma, Q.-L., Yang, F., Calon, F., Ubeda, O. J., Hansen, J. E., Weisbart, R. H., Beech, W., Frautschy, S. A., & Cole, G. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708034200 · Cited by 128
Accelerated Age-Related Cognitive Decline and Neurodegeneration, Caused by Deficient DNA Repair
Borgesius, N. Z., de Waard, M. C., van der Pluijm, I., Omrani, A., Zondag, G. C. M., van der Horst, G. T. J., Melton, D. W., Hoeijmakers, J. H. J., Jaarsma, D., & Elgersma, Y. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1589-11.2011 · Cited by 126
Subramanian, J., Savage, J. C., & Tremblay, M.-È. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592607 · Cited by 127
Yang, X., Yao, C., Tian, T., Li, X., Yan, H., Wu, J., Li, H., Pei, L., Liu, D., Tian, Q., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.151 · Cited by 136
Alzheimer's Disease and the Amyloid β-Protein
Walsh, D. M., & Teplow, D. B. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00012-6 · Cited by 137
Pitt, J., Roth, W., Lacor, P., Smith, A. B., Blankenship, M., Velasco, P., De Felice, F., Breslin, P., & Klein, W. L. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.07.018 · Cited by 134
“These sources include various synthetic preparations, naturally-secreted oAβs, transgenic mouse AD models, and human AD brain-derived extracts (Deshpande et al., 2006; Walsh et al., 2002; Oddo et al., 2003; Jacobsen et al., 2006; Knobloch et al., 2007; Lacor et al., 2004).”
BackgroundSpines, plasticity, and cognition in Alzheimer's model mice
Spires-Jones, T., & Knafo, S. (2012) · Neural Plasticity · doi:10.1155/2012/319836 · Cited by 133
The role of intracellular amyloid β in Alzheimer's disease
Li, M., Chen, L., Lee, D. H. S., Yu, L., & Zhang, Y. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.08.002 · Cited by 135
Kazim, S. F., Seo, J. H., Bianchi, R., Larson, C. S., Sharma, A., Wong, R. K. S., Gorbachev, K., & Pereira, A. C. (2021) · eNeuro · doi:10.1523/eneuro.0418-20.2020 · Cited by 133
Widespread Changes in Dendritic Spines in a Model of Alzheimer's Disease
Knafo, S., Alonso-Nanclares, L., Gonzalez-Soriano, J., Merino-Serrais, P., Fernaud-Espinosa, I., Ferrer, I., & DeFelipe, J. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn111 · Cited by 132
Excitatory-inhibitory imbalance in Alzheimer's disease and therapeutic significance
Vico Varela, E., Etter, G., & Williams, S. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.04.010 · Cited by 118
Amiri, H., Saeidi, K., Borhani, P., Manafirad, A., Ghavami, M., & Zerbi, V. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn4001582 · Cited by 113
Expression of β-Amyloid Induced Age-Dependent Presynaptic and Axonal Changes in Drosophila
Zhao, X.-L., Wang, W.-A., Tan, J.-X., Huang, J.-K., Zhang, X., Zhang, B.-Z., Wang, Y.-H., YangCheng, H.-Y., Zhu, H.-L., Sun, X.-J., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3699-09.2010 · Cited by 130
“…of basal transmission and LTP at hippocampal CA3–CA1 synapses of these transgenic mice (Larson et al., 1999; Selkoe, 2002; Oddo et al., 2003; Jacobsen et al., 2006), although other studies failed to observe either or both of these functional changes in vivo or in brain slices (Chapman et…”
ResultBezzina, C., Verret, L., Juan, C., Remaud, J., Halley, H., Rampon, C., & Dahan, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119910 · Cited by 117
Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease
Penzes, P., & VanLeeuwen, J.-E. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.01.003 · Cited by 114
Hooijmans, C. R., Graven, C., Dederen, P. J. W. C., Tanila, H., van Groen, T., & Kiliaan, A. J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.063 · Cited by 130
Alzheimer’s disease as oligomeropathy
Ono, K. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2017.08.010 · Cited by 129
Adlard, P. A., Bica, L., White, A. R., Nurjono, M., Filiz, G., Crouch, P. J., Donnelly, P. S., Cappai, R., Finkelstein, D. I., & Bush, A. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017669 · Cited by 119
Lee, A., Kondapalli, C., Virga, D. M., Lewis, T. L., Koo, S. Y., Ashok, A., Mairet-Coello, G., Herzig, S., Foretz, M., Viollet, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32130-5 · Cited by 112
Hinrich, A. J., Jodelka, F. M., Chang, J. L., Brutman, D., Bruno, A. M., Briggs, C. A., James, B. D., Stutzmann, G. E., Bennett, D. A., Miller, S. A., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505846 · Cited by 127
Zhu, H., Yan, H., Tang, N., Li, X., Pang, P., Li, H., Chen, W., Guo, Y., Shu, S., Cai, Y., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01943-0 · Cited by 119
Synaptic Dysfunction in Alzheimer’s Disease
Marcello, E. E., Epis, R., Saraceno, C., & Luca, M. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_25 · Cited by 125
Liu, L., Orozco, I. J., Planel, E., Wen, Y., Bretteville, A., Krishnamurthy, P., Wang, L., Herman, M., Figueroa, H. Y., Yu, W. H., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.03.005 · Cited by 120
Alzheimer's disease: β‐amyloid plaque formation in human brain
Seeman, P., & Seeman, N. (2011) · Synapse · doi:10.1002/syn.20957 · Cited by 97
Effects of stress hormones on the brain and cognition: Evidence from normal to pathological aging
Souza‐Talarico, J. N., Marin, M., Sindi, S., & LUPIEN, S. J. (2011) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642011dn05010003 · Cited by 117
Steele, J. W., Lachenmayer, M. L., Ju, S., Stock, A., Liken, J., Kim, S. H., Delgado, L. M., Alfaro, I. E., Bernales, S., Verdile, G., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.106 · Cited by 113
Insights into Alzheimer disease pathogenesis from studies in transgenic animal models
Schaeffer, E. L., Figueiró, M., & Gattaz, W. F. (2011) · Clinics · doi:10.1590/s1807-59322011001300006 · Cited by 114
Liu, B., Kou, J., Li, F., Huo, D., Xu, J., Zhou, X., Meng, D., Ghulam, M., Bobkov, A., Gao, X., et al. (2020) · Aging · doi:10.18632/aging.103179 · Cited by 114
Emerging Link between Alzheimer’s Disease and Homeostatic Synaptic Plasticity
Jang, S.-S., & Chung, H. J. (2016) · Neural Plasticity · doi:10.1155/2016/7969272 · Cited by 89
Majercak, J., Ray, W. J., Espeseth, A., Simon, A., Shi, X.-P., Wolffe, C., Getty, K., Marine, S., Stec, E., Ferrer, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605461103 · Cited by 95
Wang, D., Govindaiah, G., Liu, R., De Arcangelis, V., Cox, C. L., & Xiang, Y. K. (2010) · The FASEB Journal · doi:10.1096/fj.10-156661 · Cited by 95
Amyloid plaque formation precedes dendritic spine loss
Bittner, T., Burgold, S., Dorostkar, M. M., Fuhrmann, M., Wegenast-Braun, B. M., Schmidt, B., Kretzschmar, H., & Herms, J. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1047-8 · Cited by 94
Zhao, G., Liu, H. L., Zhang, H., & Tong, X. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.038 · Cited by 109
Krezymon, A., Richetin, K., Halley, H., Roybon, L., Lassalle, J.-M., Francès, B., Verret, L., & Rampon, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076497 · Cited by 86
Hettiarachchi, N., Dallas, M., Al-Owais, M., Griffiths, H., Hooper, N., Scragg, J., Boyle, J., & Peers, C. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.529 · Cited by 98
Shah, D., Praet, J., Latif Hernandez, A., Höfling, C., Anckaerts, C., Bard, F., Morawski, M., Detrez, J. R., Prinsen, E., Villa, A., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.010 · Cited by 100
Pirttimaki, T. M., Codadu, N. K., Awni, A., Pratik, P., Nagel, D. A., Hill, E. J., Dineley, K. T., & Parri, H. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081828 · Cited by 103
“Importantly our study shows that Aβ1-42 levels are elevated in the first two postnatal weeks, long before synaptic and cognitive deficits can be detected [13,36,37] at 5-6 months and coincide with insoluble Aβ1-42 deposition [48,49].”
BackgroundZameer, A., Kasturirangan, S., Emadi, S., Nimmagadda, S. V., & Sierks, M. R. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.068 · Cited by 103
Kaczorowski, C. C., Sametsky, E., Shah, S., Vassar, R., & Disterhoft, J. F. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.09.003 · Cited by 98
Luo, F. R., Rustay, N. R., Ebert, U., Hradil, V. P., Cole, T. B., Llano, D. A., Mudd, S. R., Zhang, Y., Fox, G. B., & Day, M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.005 · Cited by 106
Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease
Lee, L., Dale, E., Staniszewski, A., Zhang, H., Saeed, F., Sakurai, M., Fà, M., Orozco, I. J., Michelassi, F. E., Akpan, N., et al. (2014) · Scientific Reports · doi:10.1038/srep07190 · Cited by 102
Transthyretin influences spatial reference memory
Sousa, J. C., Marques, F., Dias-Ferreira, E., Cerqueira, J., Sousa, N., & Palha, J. A. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.07.006 · Cited by 102
IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology
St‐Amour, I., Paré, I., Tremblay, C., Coulombe, K., Bazin, R., & Calon, F. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-54 · Cited by 102
Structural Plasticity of the Hippocampus in Neurodegenerative Diseases
Weerasinghe-Mudiyanselage, P. D. E., Ang, M. J., Kang, S., Kim, J., & Moon, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063349 · Cited by 101
Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice
Schafer, M. J., Alldred, M. J., Lee, S. H., Calhoun, M. E., Petkova, E., Mathews, P. M., & Ginsberg, S. D. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.043 · Cited by 97
Rahimi, F., Shanmugam, A., & Bitan, G. (2008) · Current Alzheimer Research · doi:10.2174/156720508784533358 · Cited by 88
Emerging pathways driving early synaptic pathology in Alzheimer's disease
Briggs, C. A., Chakroborty, S., & Stutzmann, G. E. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.088 · Cited by 92
Faucher, P., Mons, N., Micheau, J., Louis, C., & Beracochea, D. J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00245 · Cited by 100
Neuron-Glia Interactions as Therapeutic Targets in Neurodegeneration
Salmina, A. B. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0988 · Cited by 86
Yang, W., Zhou, X., Zimmermann, H. R., Cavener, D. R., Klann, E., & Ma, T. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.005 · Cited by 87
Modulation of synaptic plasticity by exercise
Bettio, L. E. B., Thacker, J. S., Hutton, C. P., & Christie, B. R. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.07.002 · Cited by 96
Early locus coeruleus degeneration and olfactory dysfunctions in Tg2576 mice
Guérin, D., Sacquet, J., Mandairon, N., Jourdan, F., & Didier, A. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.020 · Cited by 94
Canas, P. M., Simões, A. P., Rodrigues, R. J., & Cunha, R. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.026 · Cited by 94
Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer’s disease
Epis, R., Marcello, E. E., Gardoni, F., Vastagh, C., Malinverno, M., Balducci, C., Colombo, A. V., Borroni, B., Vara, H., Dell’Agli, M., et al. (2010) · Brain · doi:10.1093/brain/awq217 · Cited by 93
Pathogenesis of Abeta Oligomers in Synaptic Failure
Sivanesan, S., Tan, A., & Rajadas, J. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310030011 · Cited by 86
Pitt, J., Wilcox, K. C., Tortelli, V., Diniz, L. P., Oliveira, M. S., Dobbins, C., Yu, X.-W., Nandamuri, S., Gomes, F. C. A., DiNunno, N., et al. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-06-0416 · Cited by 84
Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's disease
Calissano, P., Matrone, C., & Amadoro, G. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20759 · Cited by 86
Fanelli, F., Sepe, S., D’Amelio, M., Bernardi, C., Cristiano, L., Cimini, A., Cecconi, F., Ceru', M. P., & Moreno, S. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-8 · Cited by 76
Alzheimer's Disease and Amyloid: Culprit or Coincidence?
Skaper, S. D. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00011-9 · Cited by 91
D'Angelo, F., Vignaud, H., Di Martino, J., Salin, B., Devin, A., Cullin, C., & Marchal, C. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010108 · Cited by 75
Cummings, D. M., Liu, W., Portelius, E., Bayram, S., Yasvoina, M., Ho, S.-H., Smits, H., Ali, S. S., Steinberg, R., Pegasiou, C.-M., et al. (2015) · Brain · doi:10.1093/brain/awv127 · Cited by 81
Dual role of nitric oxide in Alzheimer's disease
Azargoonjahromi, A. (2023) · Nitric Oxide · doi:10.1016/j.niox.2023.03.003 · Cited by 77
Jakobsson, J., Zetterberg, H., Blennow, K., Ekman, C. J., Johansson, A. G. M., & Landén, M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.231 · Cited by 89
Cattaud, V., Bezzina, C., Rey, C. C., Lejards, C., Dahan, L., & Verret, L. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.024 · Cited by 88
Cruz, Y. R., Strehaïano, M., Obaya, T. R., Rodríguez, J. C. G., & Maurice, T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160500 · Cited by 88
Pharmacological Rescue of Long-Term Potentiation in Alzheimer Diseased Synapses
Prieto, G. A., Trieu, B. H., Dang, C. T., Bilousova, T., Gylys, K. H., Berchtold, N. C., Lynch, G., & Cotman, C. W. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2774-16.2016 · Cited by 78
Lee, S., Chu, K., Park, J., Jung, K., Jeon, D., Lim, J., Lee, S. K., Kim, M., & Roh, J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07534.x · Cited by 84
Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice
Matthews, D. G., Caruso, M., Murchison, C. F., Zhu, J. Y., Wright, K. M., Harris, C. J., Gray, N. E., Quinn, J. F., & Soumyanath, A. (2019) · Antioxidants · doi:10.3390/antiox8120630 · Cited by 86
“5 months) [68,69] with a corresponding decrease in synaptic density markers [70] prior to Aβ plaque development (10 months) [71] and cognitive deficiencies (one year) [72,73].”
BackgroundLee, S. H., Kim, K.-R., Ryu, S.-Y., Son, S., Hong, H. S., Mook-Jung, I., Lee, S.-H., & Ho, W.-K. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0465-12.2012 · Cited by 86
Benitez, D. P., Jiang, S., Wood, J., Wang, R., Hall, C. M., Peerboom, C., Wong, N., Stringer, K. M., Vitanova, K. S., Smith, V. C., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00457-0 · Cited by 78
Astrocytes and synaptic plasticity in health and disease
Singh, A., & Abraham, W. C. (2017) · Experimental Brain Research · doi:10.1007/s00221-017-4928-1 · Cited by 86
Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons
Kelly, B. L., & Ferreira, A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.03.047 · Cited by 85
Aβ oligomers inhibit synapse remodelling necessary for memory consolidation
Freir, D. B., Fedriani, R., Scully, D., Smith, I. M., Selkoe, D. J., Walsh, D. M., & Regan, C. M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.01.001 · Cited by 85
Parachikova, A. I., & Cotman, C. W. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.001 · Cited by 85
Wang, Y., Yin, H., Wang, L., Shuboy, A., Lou, J., Han, B., Zhang, X., & Li, J. (2013) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x13500055 · Cited by 80
Niikura, T., Sidahmed, E., Hirata‐Fukae, C., Aisen, P. S. S., & Matsuoka, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016259 · Cited by 84
Chaalal, A., Poirier, R., Blum, D., Laroche, S., & Enderlin, V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1111-z · Cited by 83
Metadata
- Authors
- Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., & Bloom, F. E.
- Affiliations
- Wyeth (US)
- Neurome, Inc., La Jolla, CA 92037; and
- Icahn School of Medicine at Mount Sinai (US)
- Scripps Research Institute (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-03-20
- Volume
- 103
- Issue
- 13
- Pages
- 5161-5166
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1405622
- OpenAlex
- W2136901555
- Cited by
- 701
- References
- 44
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 26 · 2023: 31 · 2022: 24 · 2021: 32 · 2020: 26 · 2019: 32 · 2018: 35 · 2017: 28 · 2016: 42 · 2015: 26 · 2014: 40 · 2013: 35 · 2012: 46
- FWCI
- 30.71
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, dendritic spine density, long-term potentiation, dentate gyrus, perforant path, contextual fear conditioning, memory impairment, amyloid-beta 42/40 ratio, amyloid plaques, reactive astrocytes, microglia, entorhinal cortex
- MeSH terms
- Aging, Alzheimer Disease, Animals, Behavior, Animal, Brain, Disease Models, Animal, Fear, Memory, Mice, Transgenic, Organ Size, Spine, Synapses, Time Factors, Amyloid beta-Peptides, Synaptophysin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.